Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASTERS: BHR-200 for Prostate Cancer
NCT02349386Phase 2Terminated
- Sponsor
- BHR Pharmaceuticals
- Start
- Jul 2015
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol topical in prostate cancer (PCa), sponsored by BHR Pharmaceuticals. Started Jul 2015; status: terminated.
02
Drugs
estradiol topical
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02349386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349386.